Sign In
Buy NMRD
$0.0002
+0 (+0%)
At Close: Jun 03, 2026
Nemaura Medical Inc. (NASDAQ: NMRD) ("Nemaura" or the "Company"), a medical technology company focused on developing micro-systems-based wearable diagnostic devices and digital solutions for the medic
Nemaura Medical: A Diabetes-Oriented Med-Tech Play
08:39pm, Friday, 20'th Mar 2020
The company's continuous glucose monitor is a potential breakthrough in the diabetes diagnostics space, and also the reason why its stock has gained momentum Continue reading...
Nemaura Medical Launches Non-Invasive Glucose Monitor in the US
04:16pm, Friday, 20'th Mar 2020
FDA feedback leads to continuous glucose monitor placement into the wellness device category New York, New York--(Newsfile Corp. - March 20, 2020) - Small Caps Daily recently published an article on N
Nemaura To Prepare for Launch of sugarBEAT® CGM In the U.S. Following FDA Feedback
11:00am, Wednesday, 18'th Mar 2020
Nemaura Medical Inc. (NASDAQ: NMRD) ("Nemaura" or the "Company"), a medical technology company focused on developing micro-systems-based wearable diagnostic devices and currently commercializing sugar
The Zacks Analyst Blog Highlights: HP, DexCom And Western Digital
12:00am, Tuesday, 17'th Mar 2020
Stocks Analysis by Zacks Investment Research covering: FTSE 100, S&P 500, CAC 40, DAX. Read Zacks Investment Research's latest article on Investing.com
Mid-Morning Market Update: Markets Open Lower As Federal Reserve Cuts Interest Rates To Zero
02:37pm, Monday, 16'th Mar 2020
Following the market opening Monday, the Dow traded down 8.73% to 21,162.41 while the NASDAQ fell 8.26% to 7,224.07. The S&P also fell, dropping 8.10% to 2,491.38. South Korea...
Nemaura Medical Enters Into Multiple Verbal Non-Binding Agreements for its sugarBEAT® Platform
11:00am, Tuesday, 10'th Mar 2020
Nemaura Medical, Inc. (NASDAQ: NMRD) ("Nemaura" or the "Company"), a medical technology company focused on developing micro-systems-based wearable diagnostic devices and currently commercializing suga
Nemaura Medical Launches sugarBEAT® App on Play Store Ahead of its Planned Commercial Launch of BEAT®diabetes Subscription Service
12:00pm, Tuesday, 03'rd Mar 2020
Nemaura Medical, Inc. (NASDAQ: NMRD) ("Nemaura" or the "Company"), a medical technology company focused on developing micro-systems-based wearable diagnostic devices and currently commercializing suga
80 Biggest Movers From Yesterday
10:32am, Wednesday, 26'th Feb 2020
Gainers
Nemaura Medical Inc. (NASDAQ: NMRD) shares jumped 77.4% to close at $5.80 on Tuesday.
Cocrystal Pharma Inc (NASDAQ: COCP) shares surged 64.7% to close at $2.19 on...
Nemaura Medical Reports Results and Provides Business Update for the Third Quarter Ended December 31, 2019
02:00pm, Tuesday, 11'th Feb 2020
The Company announced a partnership with the award-winning UK-based company, Changing Health, to bring digital behavior programs to improve the management, reversal and prevention of Type 2 diabetes i
Sepekan Jakarta, banjir hingga revitalisasi Monas
01:13pm, Sunday, 09'th Feb 2020
Beragam berita dan peristiwa di Kota Metropolitan Jakarta dan sekitarnya terjadi selama sepekan terakhir telah diwartakan Kantor Berita ANTARA dan masih layak ...
The Daily Biotech Pulse: Acceleron's Positive Data Readout, Surface Oncology Gets Nod For Pushing 2 Antibodies Into Clinics
12:12pm, Tuesday, 28'th Jan 2020
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on Jan. 27) 10X Genomics Inc (NASDAQ: TXG ) Achillion Pharmace
Puluhan replika "naga emas" akan meriahkan CGM Pontianak
07:26am, Tuesday, 21'st Jan 2020
Replika naga emas sepanjang 45 meter siap memeriahkan puncak perayaan Imlek atau yang dikenal dengan Cap Go Meh di Kota Pontianak, Kalbar, tahun ...
Polda Kalbar akan kerahkan 677 personel amankan Perayaan Imlek-CGM
02:25am, Thursday, 16'th Jan 2020
Kepolisian Daerah Kalimantan Barat akan mengerahkan sebanyak 677 personel polisi untuk mengamankan Perayaan Imlek dan Cap Go Meh (CGM) tahun 2020 di provinsi ...
Bigfoot Biomedical lands $45M as it readies first diabetes product
12:01am, Thursday, 16'th Jan 2020
The money will help the company launch its first insulin-management product by the end of this year, which is likely to face stiff competition from larger rivals.
